LSU Health Shreveport has announced the Rapides Health Project, which works by providing a free three-month supply of GLP-1 agonists. You may know these by other names, such as Semaglutide, Mounjaro ...

West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is ...

A new study presented at the American Academy of Orthopedic Surgeons meeting reveals the need to stop taking GLP-1 agonists ...

Increasing access to these effective evidence-based treatments would benefit our society as a whole, not just those impacted ...

Budget hearings are over at the State Capitol, but one particular expense involving a popular weight loss drug has caught the ...

Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory ...

Novo Nordisk A/S (NYSE: NVO) has declared that its GLP-1 drugs for chronic obesity, under the brands Ozempic and Wegovy, are ...

Novo Nordisk ( NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.